31
total announcements
ENTERO.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹6,934 Cr
P/E (TTM)
55.3
P/E (Forward)
27.7
EPS (TTM)
₹28.78
52W Low
₹944.00
52W High
₹1,920.00
Dividend Yield
0.00%
Beta
-0.49
Price / Book
4.1
Debt / Equity
38.6
Revenue (TTM)
₹7,128 Cr
Gross Margin
10.62%
Operating Margin
4.36%
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange regarding allotment of Equity Shares upon exercise of stock options under the Entero Employee Stock Option Plan 2023.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company by the Designated Persons of the Company and their immediate relatives will be closed from October 1, 2026, and will remain closed up to 48 hours after the declaration of the Unaudited Financial Results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about a scheduled analyst/institutional investor meeting on September 29, 2026, to be held virtually by Arihant Capital Markets.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about a monetary penalty levied by the GST Authority - Office of Assistant Commissioner (Uttar Pradesh) on its subsidiary ACE Cardiopathy Solutions Private Limited for non-generation of the E-Invoice, which has been paid under protest.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting on September 2, 2026, at Elara Capital in Mumbai.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has announced the completion of tenure of Mr. Rajesh Shashikant Dalal as Non-Executive Independent Director, effective August 24, 2026.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has held its 8th Annual General Meeting on August 19, 2026, through video conferencing, and has made available the proceedings, voting results, and Scrutinizer's Report on its website.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about the transcript of the Earnings Call/ Conference Call held on August 10, 2026, to discuss the Company’s Unaudited Financial Results for the quarter ended June 30, 2026.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has uploaded the audio recording of its earnings call for the quarter ended June 30, 2026, on its website.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has submitted a copy of newspaper publication for unaudited financial results for the quarter ended June 30, 2026.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has released its Q1FY27 investor presentation, showcasing a 40.0% YoY revenue growth on a like-for-like basis to INR 1,940 crore, with further margin improvement and return ratios moving decisively in line.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with the reconstitution of its audit and nomination committees. The company's revenue from operations was ₹832.66 crore, and its profit before tax was ₹46.05 crore.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has revised its earnings call invitation for Q1FY27 results, changing the meeting link but not the schedule or other details.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about a scheduled earnings call with analysts and investors to discuss unaudited financial results for the quarter ended June 30, 2026.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about the incorporation of its step-down subsidiary, Qurovia Lifesciences Private Limited, with details provided in Annexure-A.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has submitted an updated annual report for the financial year 2025-26, correcting an inadvertent error in the consolidated financial statements.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has published a newspaper advertisement regarding the 8th Annual General Meeting to be held on August 19, 2026, through video conferencing.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange Annual Report for the financial year 2025-26 along with the Notice convening the 8th Annual General Meeting.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited has informed the Exchange about General Updates, including the dispatch of letters to shareholders whose email addresses are not registered with the Company or Registrar & Transfer Agent, providing the weblink of the Company's website where the Annual Report for FY 2025-26 can be accessed. The Company has also scheduled the 8th Annual General Meeting (AGM) to be held on August 19, 2026, through Video Conferencing (VC) facility / Other Audio Visual Means (OAVM).